These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21075561)

  • 1. High rates of transitions to injecting drug use among Mexican American non-injecting heroin users in San Antonio, Texas (never and former injectors).
    Valdez A; Neaigus A; Kaplan C; Cepeda A
    Drug Alcohol Depend; 2011 Apr; 114(2-3):233-6. PubMed ID: 21075561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential risk factors for injecting among Mexican American non-injecting heroin users.
    Valdez A; Neaigus A; Cepeda A
    J Ethn Subst Abuse; 2007; 6(2):49-73. PubMed ID: 18192204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin.
    Valdez A; Cepeda A; Neaigus A; Russell A
    Int J Drug Policy; 2008 Dec; 19(6):442-9. PubMed ID: 19038723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injecting transition risk and depression among Mexican American non-injecting heroin users.
    Cepeda A; Kaplan C; Neaigus A; Cano MÁ; Villarreal Y; Valdez A
    Drug Alcohol Depend; 2012 Sep; 125 Suppl 1(0 1):S12-7. PubMed ID: 22749681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility.
    Neaigus A; Gyarmathy VA; Miller M; Frajzyngier VM; Friedman SR; Des Jarlais DC
    J Acquir Immune Defic Syndr; 2006 Apr; 41(4):493-503. PubMed ID: 16652059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV seroconversion among never-injecting heroin users at baseline: no predictors identified other than starting injection.
    Bravo MJ; Vallejo F; Barrio G; Brugal MT; Molist G; Pulido J; Sordo L; de la Fuente L;
    Int J Drug Policy; 2012 Sep; 23(5):415-9. PubMed ID: 22421554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors.
    Neaigus A; Miller M; Friedman SR; Hagen DL; Sifaneck SJ; Ildefonso G; des Jarlais DC
    Addiction; 2001 Jun; 96(6):847-60. PubMed ID: 11399216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
    Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Every 'never' I ever said came true": transitions from opioid pills to heroin injecting.
    Mars SG; Bourgois P; Karandinos G; Montero F; Ciccarone D
    Int J Drug Policy; 2014 Mar; 25(2):257-66. PubMed ID: 24238956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental health of heroin users with differing injection drug use histories: A non-treatment sample of Mexican American young adult men.
    Nowotny KM; Perdue T; Cepeda A; Valdez A
    Drug Alcohol Depend; 2017 Dec; 181():124-131. PubMed ID: 29054031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits.
    Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Tross S; Perlman DC; Campbell AN; Cooper HL; Hagan H
    J Subst Abuse Treat; 2016 Dec; 71():48-53. PubMed ID: 27776677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users.
    Gyarmathy VA; Neaigus A; Miller M; Friedman SR; Des Jarlais DC
    J Acquir Immune Defic Syndr; 2002 Aug; 30(4):448-56. PubMed ID: 12138352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks.
    De P; Cox J; Boivin JF; Platt RW; Jolly AM
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):355-61. PubMed ID: 17721398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual risk behavior associated with transition to injection among young non-injecting heroin users.
    Mackesy-Amiti ME; Boodram B; Williams C; Ouellet LJ; Broz D
    AIDS Behav; 2013 Sep; 17(7):2459-66. PubMed ID: 23065126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in the barrio: An analysis of the risk and protective nature of cultural values among Mexican American substance users.
    Villarreal YR; Torres LR; Stotts AL; Ren Y; Sampson M; Klawans MR; Bordnick PS
    J Ethn Subst Abuse; 2019; 18(1):150-164. PubMed ID: 28590812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
    Vallejo F; Barrio G; Brugal MT; Pulido J; Toro C; Sordo L; Espelt A; Bravo MJ;
    J Epidemiol Community Health; 2015 Jun; 69(6):599-603. PubMed ID: 25870164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial accessibility of drug treatment facilities and the effects on locus of control, drug use, and service use among heroin-injecting Mexican American men.
    Kao D; Torres LR; Guerrero EG; Mauldin RL; Bordnick PS
    Int J Drug Policy; 2014 May; 25(3):598-607. PubMed ID: 24440123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.
    Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC
    J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing the drug-injecting networks of cocaine and heroin injectors in Montreal.
    De P; Jolly A; Cox J; Boivin JF
    Can J Public Health; 2006; 97(3):207-9. PubMed ID: 16827407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
    Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
    Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.